Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v22-EN Version v18-FR
Language English French
Date Updated 2021-02-19 2021-02-12
Drug Identification Number 02408155 02408155
Brand name AURO-VALSARTAN HCT AURO-VALSARTAN HCT
Common or Proper name Hydrochlorothiazide; valsartan Hydrochlorothiazide; valsartan
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients HYDROCHLOROTHIAZIDE VALSARTAN HYDROCHLOROTHIAZIDE VALSARTAN
Strength(s) 25MG 320MG 25MG 320MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100s, 30 100s, 30
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-25 2019-11-25
Estimated end date 2021-02-19 2021-02-19
Actual end date 2021-02-18
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Auro-Valsartan HCT 25mg/320mg (100's) available as of February 18, 2021 Auro-Valsartan HCT 25mg/320mg (30's) - Replaceable with Auro-Valsartan HCT 25mg/320mg (100's)
Health Canada comments